Immediate Impact

1 by Nobel laureates 69 standout
Sub-graph 1 of 23

Citing Papers

Renin–Angiotensin System Inhibition in Advanced Chronic Kidney Disease
2022 Standout
Chronic kidney disease
2021 Standout
2 intermediate papers

Works of Mary Rogerson being referenced

First United Kingdom Heart and Renal Protection (UK-HARP-I) study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease
2005 Nobel
A population-based study of the incidence and outcomes of diagnosed chronic kidney disease
2003

Author Peers

Author Last Decade Papers Cites
Mary Rogerson 421 189 209 18 830
Joan Fort 544 132 116 22 899
Edwin B. Toffelmire 514 185 103 23 813
Glenda V. Roberts 425 87 123 18 850
Wieneke M. Michels 660 165 225 28 983
Judith Hirsh 411 203 106 16 785
K. Scott Brimble 492 157 124 36 863
K. Simpson 413 148 137 20 745
Seung-Jung Kim 327 132 149 39 773
Karen S. Servilla 439 205 251 62 919
Adeera Levin 536 85 204 15 802

All Works

Loading papers...

Rankless by CCL
2026